Expedia Inc. (NASDAQ:EXPE) Revenue for the quarter was $1.36 billion, down 20.8% sequentially and up 17.7% year over year (22% excluding FX impact), just short of the Zacks Consensus Estimate of $1.37 billion. On Friday shares of Expedia Inc. (NASDAQ:EXPE) closed at $77.87. Company’s sales growth for last 5 years was 10.20% and EPS growth for next 5 years is recorded as 15.95%.
Raymond James cut shares of Transocean LTD (NYSE:RIG) from a market perform rating to an underperform rating in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. Transocean Ltd. (NYSE:RIG) in last trading activity moved up 3.18% to close at $18.51. Company weekly performance is 13.56% while its quarterly performance stands at -34.22%. Transocean Ltd. (NYSE:RIG) is -57.99% away from its 52 week high.
Codexis, Inc. (NASDAQ:CDXS), announced that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015, at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). On last trading day Codexis, Inc. (NASDAQ:CDXS) fell -1.89% to close at $3.64. Its volatility for the week is 7.00% while volatility for the month is 7.47%. CDXS’s sales growth for past 5 years was -8.80% and its EPS growth for past 5 years was 43.60%. Codexis, Inc. (NASDAQ:CDXS) monthly performance is 26.83%.
Repligen Corporation (NASDAQ:RGEN) announced that the Company will present at the 2015 Leerink Global Healthcare Conference to be held February 11-12 at the Waldorf Astoria hotel in New York. Management is scheduled to participate in an analyst-moderated “fireside chat” with investors at 2:40 p.m. EST on Thursday, February 12, 2015. Repligen Corporation (NASDAQ:RGEN) has 1.80% insider ownership while its institutional ownership stands at 89.70%. In last trading activity company’s stock closed at $23.79.
On 3 February, Arena Pharmaceuticals Inc (NASDAQ:ARNA) announced that Ildong Pharmaceuticals Co. Ltd. has informed Arena that the Ministry of Food and Drug Safety has approved BELVIQ for marketing for weight measurement in South Korea. On last trading day Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) decreased -0.89% to close at $4.44. Its volatility for the week is 5.31% while volatility for the month is 7.62%. ARNA’s sales growth for past 5 years was 52.70% and its EPS growth for past 5 years was 51.20%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) monthly performance is -24.10%.